SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Xcelthera, INC. – ‘DRS/A’ from 3/6/14 – ‘EX-23’

On:  Thursday, 3/6/14, at 6:31pm ET   ·   As of:  3/7/14   ·   Private-to-Public:  Filing  –  Release Delayed to:  3/6/14   ·   Accession #:  1588362-14-1   ·   File #:  377-00335

Previous ‘DRS’:  ‘DRS/A’ on 12/23/13   ·   Latest ‘DRS’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

 3/07/14  Xcelthera, INC.                   DRS/A3/06/14   16:20M

Delayed-Release Amendment to Draft Registration Statement by an Emerging Growth Company or a Foreign Private Issuer   —   Form DRS
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DRS/A       Amendment to Draft Registration Statement by an     HTML    985K 
                Emerging Growth Company or a Foreign Private                     
                Issuer                                                           
 2: DRS/A       Amendment to Draft Registration Statement by an      PDF   5.95M 
                Emerging Growth Company or a Foreign Private                     
                Issuer                                                           
 3: EX-3        Articles of Incorporation/Organization or By-Laws   HTML     13K 
 4: EX-3        Articles of Incorporation/Organization or By-Laws   HTML     21K 
 5: EX-3        Articles of Incorporation/Organization or By-Laws   HTML    102K 
 6: EX-4        Instrument Defining the Rights of Security Holders  HTML      7K 
 7: EX-10       Material Contract                                   HTML     58K 
 8: EX-10       Material Contract                                   HTML     65K 
 9: EX-23       Consent of Experts or Counsel                          1     10K 
11: EX-23       Consent of Experts or Counsel                          9±    42K 
13: EX-23       Consent of Experts or Counsel                          4±    20K 
15: EX-23       Consent of Experts or Counsel                          8±    36K 
10: EX-23       Consent of Experts or Counsel                        PDF    574K 
12: EX-23       Consent of Experts or Counsel                        PDF    689K 
14: EX-23       Consent of Experts or Counsel                        PDF    160K 
16: EX-23       Consent of Experts or Counsel                        PDF    283K 


‘EX-23’   —   Consent of Experts or Counsel



Hello Dr. Parsons, Absolutely! We will process and place this in our database next week. When you are ready to license this please contact me and we can go over your needs. I do have some flexibility to create a smaller licensing package to help you in getting the word out. If this is something you are interested in let me know. Have a great weekend! Regards, John Dear John, The company is in the process of filing confidential draft S1 and plan IPO early next year. We also offer series A convertible preferred stock to investors right now to raise funds and help the IPO process, through equity crowdfunding to accredited investors (see our website). We are very pleased with your analysis and wish to license your information very much, but may not be able to do it right now. We are comfortable to have you announce this award within your network and investors right now, and hope to license this information after we raise substantial private funds or our IPO, if it's ok with you. Best, Jun Hello Dr. Parsons, Thank you for sending over your confirmation on the Award text. We will finalize it here. What was your decision on licensing this information? Regards, John John L. Weber | Strategic Account Manager, Intellectual Property & Licensing, North America | Best Practices | Frost & Sullivan jweber@frost.com | P: 210.247.2494 | M: 210.348.1000 | F: 210.348.1003 | www.frost.com "50 Years of Growth, Innovation and Leadership" All information provided by Frost & Sullivan is proprietary information owned by Frost & Sullivan and is protected by U.S. and international copyright law and conventions. Reproduction of the information, in whole or in part, by any means is prohibited without the express written consent of Frost & Sullivan. Frost & Sullivan prohibits any reference to Frost & Sullivan Awards or its information in all types of advertising and sales collateral, in any and all types of media, including Web pages, without the written consent of Frost & Sullivan. Dear John, We feel very much honored for Xcelthera, Inc. to be selected as the recipient of the 2013 Frost & Sullivan Technology Innovation Award. We believe your independent analysis is fair and consistent with our view, and this prestigious recognition will increase the exposure of our breakthrough stem cell technology to North American Stem Cell Technology Market and investors, and help driving clinical translation of hESC research innovations for unmet medical challenges and the advance of medicine. I did not find anything need to be changed in the report. Thanks for your award. Sincerely, Xuejun H Parsons, PhD, Hello Dr. Parsons, We are pleased to announce that Xcelthera, Inc. is the recipient of the 2013 Frost & Sullivan Technology Innovation Award. This prestigious recognition is based on an extensive and independent Frost & Sullivan competitive analysis of the North American Stem Cell Technologies Market. Below you will find the 4 action items around the Award: 1. Review of the Best Practices Report The attached Best Practices report is based on in-depth interviews and primary market analysis, which has been fully funded and conducted by Frost & Sullivan's industry analyst team. The report will be posted on Frost.com for our subscription clients. As a professional courtesy, your team has the opportunity to conduct an internal review for accuracy. If you would like to suggest any edits to the report's content, please submit within 3 business days (see attached Word doc) 2. Licensing Packages for External Promotion Please note that the report and enclosed information are Frost & Sullivan intellectual property and a piece of our copyrighted research portfolio. Any public distribution or external announcements around the Frost & Sullivan Award or research findings in press releases, website postings, social media, or print fall under our corporate licensing agreement. To obtain maximum exposure for the Award we provide promotional support with the licensing agreement. I've attached the relevant licensing packages in the PDF file below. 3. Awards Banquet Frost & Sullivan will be hosting our annual Excellence Best Practices Awards Ceremony January 14, 2014 in New Orleans. Reserve tables for your executive team to attend this black tie event are included in the licensing packages. http://www.frost.com/prod/servlet/our- services-page.pag?sid=287139561 4. Examples of External Promotion Attached are the ads / marketing pieces touting the previous Frost & Sullivan Cytomedix, Athersys and Plasticell Awards, along with a link to the multimedia press release announcing the Mayo Clinic Award. http://www.cytomedix.com/Portals/121782/ docs/cmxi%20f&s%20award%20011413%2 0final.pdf http://www.athersys.com/releasedetail.cfm?r eleaseid=343735 http://www.plasticell.co.uk/category/news/ Mayo Clinic Analyst Commentary Video: http://news.mayomedicallaboratories.com/2 012/08/17/frost-sullivan-highlights-mayo- medical-laboratories-award-in-video-press- release-video/ For more information on the Frost & Sullivan Best Practices Award go to: http://www.frost.com/prod/servlet/meawards ..pag Congratulations to your team at Xcelthera! Best Regards, John John L. Weber | Global Strategic Account Manager |Copyrights & Licensing | Best Practices | Frost & Sullivan jweber@frost.com | P: 210.247.2494 | F: 210.348.1003 | Twitter: @Frost_Sullivan | www.frost.com "50 Years of Growth, Innovation and Leadership" All information provided by Frost & Sullivan is proprietary information owned by Frost & Sullivan and is protected by U.S. and international copyright law and conventions. Reproduction of the information, in whole or in part, by any means is prohibited without the express written consent of Frost & Sullivan. Frost & Sullivan prohibits any reference to Frost & Sullivan Awards or its information in all types of advertising and sales collateral, in any and all types of media, including Web pages, without the written consent of Frost & Sullivan. Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com. This email, its content and any files transmitted with it are intended solely for the addressee(s) and may be legally privileged and/or confidential. If you are not the intended recipient please delete and contact the sender by return. Messages sent via this medium may be subject to delays, non-delivery and unauthorized alteration. This email has been prepared using information believed by the author to be reliable and accurate, but Frost & Sullivan makes no warranty as to accuracy or completeness. In particular, Frost & Sullivan does not accept responsibility for changes made to this email after it was sent. Any opinions or recommendations expressed herein are solely those of the author. They may be subject to change without notice. Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com. This email, its content and any files transmitted with it are intended solely for the addressee(s) and may be legally privileged and/or confidential. If you are not the intended recipient please delete and contact the sender by return. Messages sent via this medium may be subject to delays, non-delivery and unauthorized alteration. This email has been prepared using information believed by the author to be reliable and accurate, but Frost & Sullivan makes no warranty as to accuracy or completeness. In particular, Frost & Sullivan does not accept responsibility for changes made to this email after it was sent. Any opinions or recommendations expressed herein are solely those of the author. They may be subject to change without notice. Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com. This email, its content and any files transmitted with it are intended solely for the addressee(s) and may be legally privileged and/or confidential. If you are not the intended recipient please delete and contact the sender by return. Messages sent via this medium may be subject to delays, non-delivery and unauthorized alteration. This email has been prepared using information believed by the author to be reliable and accurate, but Frost & Sullivan makes no warranty as to accuracy or completeness. In particular, Frost & Sullivan does not accept responsibility for changes made to this email after it was sent. Any opinions or recommendations expressed herein are solely those of the author. They may be subject to change without notice.

Dates Referenced Herein

This ‘DRS/A’ Filing    Date    Other Filings
Filed as of:3/7/14None on these Dates
Filed on / Release Delayed to:3/6/14
1/14/14
 List all Filings 
Top
Filing Submission 0001588362-14-000001   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 9:15:36.1pm ET